Point-of-care testing improves diabetes management in a primary care clinic in South Africa

2017 ◽  
Vol 11 (3) ◽  
pp. 248-253 ◽  
Author(s):  
Lara A. Motta ◽  
Mark D.S. Shephard ◽  
Julie Brink ◽  
Stefan Lawson ◽  
Paul Rheeder
PLoS ONE ◽  
2013 ◽  
Vol 8 (6) ◽  
pp. e65421 ◽  
Author(s):  
Colleen F. Hanrahan ◽  
Katerina Selibas ◽  
Christopher B. Deery ◽  
Heather Dansey ◽  
Kate Clouse ◽  
...  

2013 ◽  
Vol 17 (3) ◽  
pp. 368-372 ◽  
Author(s):  
A. Van Rie ◽  
L. Page-Shipp ◽  
C. F. Hanrahan ◽  
K. Schnippel ◽  
H. Dansey ◽  
...  

PLoS ONE ◽  
2014 ◽  
Vol 9 (9) ◽  
pp. e105428 ◽  
Author(s):  
Annelies Van Rie ◽  
Kate Clouse ◽  
Colleen Hanrahan ◽  
Katerina Selibas ◽  
Ian Sanne ◽  
...  

PLoS Medicine ◽  
2014 ◽  
Vol 11 (11) ◽  
pp. e1001760 ◽  
Author(s):  
Helen S. Cox ◽  
Slindile Mbhele ◽  
Neisha Mohess ◽  
Andrew Whitelaw ◽  
Odelia Muller ◽  
...  

10.2196/16266 ◽  
2020 ◽  
Vol 8 (2) ◽  
pp. e16266 ◽  
Author(s):  
Yeoree Yang ◽  
Eun Young Lee ◽  
Hun-Sung Kim ◽  
Seung-Hwan Lee ◽  
Kun-Ho Yoon ◽  
...  

Background Recent evidence of the effectiveness of mobile phone–based diabetes management systems is generally based on studies conducted in tertiary hospitals or professional diabetes clinics. Objective This study aimed to evaluate the clinical efficacy and applicability of a mobile phone–based glucose-monitoring and feedback system for the management of type 2 diabetes mellitus (T2DM) in multiple primary care clinic settings. Methods In this multicenter, cluster-randomized controlled, open trial, 13 primary care clinics in Seoul and other large cities in South Korea were voluntarily recruited. Overall, 150 (9 clinics) and 97 (4 clinics) participants with T2DM were assigned to the intervention and control groups, respectively (2:1 allocation). Every month, participants in both groups attended face-to-face physicians’ consultation for the management of diabetes in the clinic. For the intervention group, participants were required to upload their daily self-monitoring of blood glucose (SMBG) results using the mobile phone app in addition to outpatient care for 3 months. The results were automatically transmitted to the main server. Physicians had to check their patients’ SMBG results through an administrator’s website and send a short feedback message at least once a week. At baseline and 3 months, both groups had anthropometry and blood tests, including hemoglobin A1c (HbA1c), and responded to questionnaires about treatment satisfaction and compliance. Results At 3 months, participants in the intervention group showed significantly more improvement in HbA1c (adjusted mean difference to control −0.30%, 95% CI −0.50 to −0.11; P=.003) and fasting plasma glucose (−17.29 mg/dL, 95% CI −29.33 to −5.26; P=.005) than those in the control group. In addition, there was significantly more reduction in blood pressure, and the score regarding treatment satisfaction and motivation for medication adherence increased more in the intervention group than in the control group. In the subgroup analyses, the effect on glycemic control was more significant among younger patients and higher baseline HbA1c levels. Conclusions The mobile phone–based glucose-monitoring and feedback system was effective in glycemic control when applied in primary care clinic settings. This system could be utilized effectively with diverse institutions and patients. Trial Registration Clinical Research Information Service (CRIS) https://tinyurl.com/tgqawbz


2020 ◽  
Vol 11 ◽  
pp. 215013272094269 ◽  
Author(s):  
Morihito Takita ◽  
Tomoko Matsumura ◽  
Kana Yamamoto ◽  
Erika Yamashita ◽  
Kazutaka Hosoda ◽  
...  

Introduction: The primary care clinic plays a major role in triage for coronavirus disease 2019 (COVID-19), where seroprevalence in the setting of primary care clinic remains less clear. As a point-of-care immunodiagnostic test for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the serosurvey represents an alternative to the polymerase chain reaction (PCR) test to measure the magnitude of COVID-19 outbreak in the communities lacking sufficient diagnostic capability for PCR testing. Methods: We assessed seropositivity for the SARS-CoV-2 IgG between April 21 and May 20, 2020, at 2 primary care clinics in Tokyo, Japan. Results: The overall positive percentage of SARS-CoV-2 IgG was 3.83% (95% confidence interval [CI]: 2.76-5.16) for the entire cohort (n = 1071). The 23 special wards of central Tokyo exhibited a significantly higher prevalence compared with the other areas of Tokyo after classification by residence ( P = .02, 4.68% [3.08-6.79] vs 1.83 [0.68-3.95] in central and suburban Tokyo, respectively). In central Tokyo, the southern area showed the highest seroprevalence compared with the other areas (7.92% [3.48-15.01]), corresponding to the cumulative number of confirmed COVID-19 patients by PCR test reported by the Tokyo Metropolitan Government. Conclusion: The seroprevalence surveyed in this study was too low for herd immunity, suggesting the need for robust disease control and prevention. A regional-level approach, rather than state- or prefectural-level, could be of importance in ascertaining detailed profiles of the COVID-19 outbreak.


AIDS Care ◽  
2010 ◽  
Vol 22 (11) ◽  
pp. 1332-1339 ◽  
Author(s):  
Kartik K. Venkatesh ◽  
Guy de Bruyn ◽  
Mark N. Lurie ◽  
Kgotso Lentle ◽  
Nkeko Tshabangu ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document